Susquehanna Fundamental Investments’s Inovio Pharmaceuticals INO Stock Holding History

Susquehanna Fundamental Investments’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-65,669	Closed	-$120K	–	1152
2024 Q4	$120K	Buy	+65,669	New	+$291K	﹤0.01%	1035
2024 Q2	$808K	Sell	99,991 -6,800	-6%	-$71.6K	0.02%	596
2024 Q1	$1.48M	Buy	+106,791	New	+$922K	0.07%	278
2021 Q4	–	Sell	-2,615	Closed	-$225K	–	1601
2021 Q3	$225K	Sell	2,615 -8,534	-77%	-$856K	﹤0.01%	1503
2021 Q2	$1.24M	Buy	11,149 +1,490	+15%	+$143K	0.02%	760
2021 Q1	$1.08M	Buy	+9,659	New	+$1.27M	0.02%	861

Other funds holding INO

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna Fundamental Investments's INO Position: Q1 2025 in Review

Susquehanna Fundamental Investments sold out of Inovio Pharmaceuticals (INO) in Q1 2025, closing a stake of 65,669 shares — an estimated $120K sold.

Susquehanna Fundamental Investments first reported a position in INO in Q1 2021 and held it in 6 quarters. The position peaked at $1.48M in Q1 2024. 107 funds tracked by Wall St. Rank hold INO as of Q1 2025.

Susquehanna Fundamental Investments reported no remaining Inovio Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 65,669 Inovio Pharmaceuticals shares in Q1 2025, an estimated $120K.
Susquehanna Fundamental Investments first reported a position in Inovio Pharmaceuticals in Q1 2021 and held it in 6 quarters.
Susquehanna Fundamental Investments's Inovio Pharmaceuticals position peaked at $1.48M in Q1 2024.
107 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2025, filed 14 May 2025.